Comparative Effectiveness of Interventions for Stroke Prevention in Atrial Fibrillation: A Network Meta‐Analysis
BackgroundThe goal of this study was to compare the safety and effectiveness of individual antiembolic interventions in nonvalvular atrial fibrillation (AF): novel oral anticoagulants (NOACs) (apixaban, dabigatran, edoxaban, and rivaroxaban); vitamin K antagonists (VKA); aspirin; and the Watchman de...
Main Authors: | Larisa G. Tereshchenko, Charles A. Henrikson, Joaquin Cigarroa, Jonathan S. Steinberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-05-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.116.003206 |
Similar Items
-
Non-Pharmacological Stroke Prevention in Atrial Fibrillation
by: Iñigo Anduaga, et al.
Published: (2023-08-01) -
Net Clinical Benefit of Left Atrial Appendage Closure Versus Warfarin in Patients With Atrial Fibrillation: A Pooled Analysis of the Randomized PROTECT‐AF and PREVAIL Studies
by: Tom F. Brouwer, et al.
Published: (2019-12-01) -
THROMBOSIS OF LEFT ATRIAL APPENDAGE DURING THERAPY WITH DIRECT ORAL ANTICOAGULANT. CLINICAL CASE
by: I. S. Daaboul, et al.
Published: (2018-07-01) -
Risk of Death and Ischemic Stroke in Patients with Atrial Arrhythmia and Thrombus or Sludge in Left Atrial Appendage at One-Year Follow-Up
by: Katarzyna Kosmalska, et al.
Published: (2022-02-01) -
Nine‐year trend of oral anticoagulant use in patients with embolic stroke due to nonvalvular atrial fibrillation
by: Chisa Asahina, et al.
Published: (2020-10-01)